The application was described as 'finely balanced, but the report suggests that approval would be huge contribution to the area.
Ophthalmic company, based in Cheshire to launch new products as it eyes company growth in 2023
By Rich Wilcock
21st Feb 2023 | Healthcare
The Macclesfield-based company is setting its sights on growth with an expanded team and new products.
"You need an incentive to invest" according to AstraZeneca boss
By Rich Wilcock
10th Feb 2023 | Healthcare
Higher corporation tax blamed for Macclesfield missing out on AstraZeneca's new manufacturing facility.
The company expects another strong performance in 2023, despite COVID vaccine demand dropping.
